[Summary] Guangdong Provincial Engineering Technology Research Center for Cardio
Hunan Nanxin Pharmaceutical Joint-stock Co., Ltd. is a holding subsidiary of Hunan Pharmaceutical Development Investment Group Co., Ltd. Founded in 2006 with a registered capital of 274 million yuan, it was listed on the Science and Technology Innovation Board in 2020 (stock code: 688189). The company focuses on the research and development of anti-infective, cardiovascular and cerebrovascular, and antipyretic and analgesic drugs, holding 16 new drug certificates and over 10 patents, and has in-depth cooperation with institutions such as the Academy of Military Medical Sciences. It holds 2 drug production licenses, 4 GMP certifications, and 62 production approvals. With 4 subsidiaries, its annual production capacity includes 12.25 million bottles of infusion and 650 million tablets/capsules of solid preparations, ranking among the top in the industry in terms of quality and scale.
What does Guangzhou Nanxin Pharmaceutical Co., Ltd. require? Who is Guangzhou Nanxin Pharmaceutical Co., Ltd. hiring? recruitment: 经营管理类占比最多占59.7%,其次是销售类占20.8%. What education can get in at ? 本科占比最多占85.7%,其次是不限占7.8%. High education required at ? 硕士占5.2%. Work experience required at ? 不限占比最多占44.2%,其次是5-10年占40.3%. Where are the job locations at ? 广州占比最多占58.4%,其次是郑州占5.2%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows